Listed by the USPTO as NATARAJAN, MEERA
Tech Center 1600 • Art Units: 1643 1645 1646 1674
This examiner grants 63% of resolved cases
NATARAJAN, MEERA has resolved 765 cases in Tech Center 1600 and Art Unit 1643. The allowance rate is 62.6%, and the median time to allowance is 1178 days. The record shows a substantial examination history with a moderate allowance outcome and extended pendency. Applicants should prepare for substantive prosecution and align filing, continuation, and product plans accordingly.
The interview lift is 17.9%, suggesting that a well-prepared interview may improve the effectiveness of an overall response strategy. Santersus AG, Xencor Inc., and Hoffmann-La Roche Inc. are the leading listed companies. MEDLER FERRO WOODHOUSE & MILLS PLLC, TROUTMAN PEPPER LOCKE LLP, and MARSHALL, GERSTEIN & BORUN LLP are the principal listed firms. Their activity identifies recurring practice experience in the unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18706314 | PRODUCTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA | Non-Final OA | McMaster University |
| 17621303 | IN SITU RECRUITMENT, REPROGRAMMING, AND RELEASE OF CAR-T CELLS | Non-Final OA | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| 18338313 | NOVEL METHOD FOR PRODUCING ANTIBODIES | Non-Final OA | TSINGHUA UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy62.6% of resolved applications examined by Meera Natarajan were allowed (765 resolved cases), compared with 41.5% across Art Unit 1643 over the last five years.
This examiner's interview lift is +17.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Meera Natarajan took 1,178 days on average from filing to allowance.
Meera Natarajan examines applications in Art Unit 1643 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
